D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
HRMY holding history
Harmony Biosciences Holdings, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HRMY overviewAll 13F holders of HRMYFull Q2 2026 holdings
- Shares (Q2 2026)
- 52,879
- Value
- $1.93M
- % of portfolio
- <0.1%
- Quarters held
- 19
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 52,879 | $1.93M | <0.1% | −48,548−47.9% | Reduced | Holders |
| Q1 2026 | 101,427 | $2.84M | <0.1% | −12,883−11.3% | Reduced | Holders |
| Q4 2025 | 114,310 | $4.28M | <0.1% | −78,317−40.7% | Reduced | Holders |
| Q3 2025 | 192,627 | $5.31M | <0.1% | −60,354−23.9% | Reduced | Holders |
| Q2 2025 | 252,981 | $7.99M | <0.1% | −66,723−20.9% | Reduced | Holders |
| Q1 2025 | 319,704 | $10.6M | <0.1% | −160,901−33.5% | Reduced | Holders |
| Q4 2024 | 480,605 | $16.5M | <0.1% | +124,656+35.0% | Added | Holders |
| Q3 2024 | 355,949 | $14.2M | <0.1% | +45,945+14.8% | Added | Holders |
| Q2 2024 | 310,004 | $9.35M | <0.1% | +30,569+10.9% | Added | Holders |
| Q1 2024 | 279,435 | $9.38M | <0.1% | −2,321−0.8% | Reduced | Holders |
| Q4 2023 | 281,756 | $9.10M | <0.1% | +13,943+5.2% | Added | Holders |
| Q3 2023 | 267,813 | $8.78M | <0.1% | +27,352+11.4% | Added | Holders |
| Q2 2023 | 240,461 | $8.46M | <0.1% | +45,975+23.6% | Added | Holders |
| Q1 2023 | 194,486 | $6.35M | <0.1% | −29,485−13.2% | Reduced | Holders |
| Q4 2022 | 223,971 | $12.3M | <0.1% | +177,772+384.8% | Added | Holders |
| Q3 2022 | 46,199 | $2.05M | <0.1% | +9,423+25.6% | Added | Holders |
| Q2 2022 | 36,776 | $1.79M | <0.1% | +8,317+29.2% | Added | Holders |
| Q1 2022 | 28,459 | $1.39M | <0.1% | +28,459 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −44,765−100.0% | Sold out | Holders |
| Q2 2021 | 44,765 | $1.26M | <0.1% | +44,765 | New | Holders |